Liver Disorder
16 drugs881 FAERS reportsMedDRA PT
GET
/api/v1/reaction/liver-disorderReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D008107
Pathological processes of the LIVER.
Source: U.S. National Library of Medicine — MeSH (Liver Diseases)
Drugs reporting Liver Disorder (16)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Calcium Silicate150%
- 2Sertaconazole74.5%
- 3Taletrectinib24.3%
- 4Hepatitis B Immune Globulin23.9%
- 5Miglitol343.6%
- 6Terlipressin103.5%
- 7Tremelimumab1223.1%
- 8Auranofin62.9%
- 9Toremifene102.4%
- 10Rifaximin4822.4%
- 11Cholic Acid82.0%
- 12Avacopan1122.0%
- 13Carteolol61.8%
- 14Nitisinone161.7%
- 15Epinastine171.5%
- 16Sotorasib461.5%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Hepatic Function Abnormal7 shared · 0.16
- Hepatic Failure3 shared · 0.12
- Liver Function Test Increased3 shared · 0.10
- Hepatic Encephalopathy2 shared · 0.10
- Hepatic Cirrhosis2 shared · 0.10
- Drug Eruption2 shared · 0.09
- Liver Transplant2 shared · 0.09
- Interstitial Lung Disease4 shared · 0.08
- Alanine Aminotransferase Increased5 shared · 0.06
- Aspartate Aminotransferase Increased4 shared · 0.06
Literature
Recent PubMed references pinned to Liver Diseases as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Zinc deficiency and sarcopenia define a metabolic frailty phenotype predicting hepatic encephalopathy and early mortality in cirrhosis.Metabolic brain disease · 2026 · Méndez-Guerrero O, Carranza-Carrasco A, Guerrero-Guerrero R, et al.PMID 42207388DOI 10.1007/s11011-026-01879-9
- Integrated Serum Pharmacochemistry, Network Pharmacology, and Experimental Validation to Explore the Active Components and Potential Mechanisms of Jujube Against Alcoholic Liver Disease.Biomedical chromatography : BMC · 2026 · Xu W, Han J, Weng Z, et al.PMID 42207218DOI 10.1002/bmc.70503
- Frequency and associated factors of hepatic hemangioma in systemic lupus erythematosus patients undergoing abdominal imaging: a retrospective cohort study.Rheumatology international · 2026 · Üsküdar Cansu D, Uludoğan BC, Yıldırım R, et al.PMID 42207195DOI 10.1007/s00296-026-06164-7
- TIME-RESTRICTED EATING IN MASLD: THE IMPERATIVE TO PRESERVE MUSCLE MASS AND PREVENT WEIGHT CYCLING FOR SUSTAINABLE CLINICAL BENEFIT.Arquivos de gastroenterologia · 2026 · Ketenci YB, Demiröz H, Akca M, et al.PMID 42207075DOI 10.1590/S0004-2803.24612025-111
- Fasciola Metacercaria Contamination in Wetland Pastures and Its Association With Forage Characteristics Across Agro-Ecological Zones: Case of Gamo Zone, Southern Ethiopia.Veterinary medicine and science · 2026 · Milkyas M, Kechero Y, Kaba T, et al.PMID 42206895DOI 10.1002/vms3.71003
- Learning ordinal representation across MRI sequences for liver fibrosis staging.Medical physics · 2026 · Huo J, Wang Y, Wu N, et al.PMID 42206568DOI 10.1002/mp.70504
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.